Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets

Elke Tatjana Aristizabal Prada(Ludwig-Maximilians-Universität München), Christoph J. Auernhammer(LMU Klinikum)
Endocrine Connections
November 17, 2017
10.1530/ec-17-0286
Cited by 32

Related Papers

Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
|Cancers|2020|39
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro
|Neuroendocrinology|2017|23
Upregulation of SSTR2 Expression and Radioligand Binding of [<sup>18</sup>F]SiTATE in Neuroendocrine Tumour Cells with Combined Inhibition of Class I HDACs and LSD1
|Neuroendocrinology|2025|4